35
Participants
Start Date
February 28, 2014
Primary Completion Date
August 31, 2014
Study Completion Date
November 30, 2014
ITI-007
ITI-007 for Part 1
Placebo
ITI-007 for Part 1
ITI-007
ITI-007 for Part 2
Placebo
Placebo for Part 2
Glendale
Lead Sponsor
Intra-Cellular Therapies, Inc.
INDUSTRY